Few lessons learnt during the pandemic have been as clear as how essential progress in the use of real-world evidence (RWE) across the value chain is for the successful transition to a digitally enabled, value-driven healthcare system.
In our latest webinar, RWE leaders will share insight on how advances in analytics, data quality and collection, interoperability and new collaborations are further enabling RWE’s value.
From improving trial efficiency with novel design approaches and identifying unmet need in R&D, to enabling outcomes-based pricing agreements, providing real-time insights to HCPs and providing more strategic insights to enhance decision-making across the value chain – the list of how RWE is being applied is growing equally as long.
Experts sharing their insights include:
- Jennie Medin, Executive Director, Head Real World Science & Digital, AstraZeneca
- Ramon Hernandez, Global Head of Development Real World Evidence, Sanofi
- Gilles Paubert, Global Head, Cegedim Health Data
- MODERATOR: Nigel Hughes, Scientific Director, Janssen